CME

Disclosure Policy
Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.

Faculty Disclosure
The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationship(s), which have been resolved through an established COI resolution process, and have stated that these reported relationship(s) will not have any impact on their ability to give an unbiased presentation.

James W. Hoekstra, MD
Consulting fees/advisory boards: sanofi-aventis U.S., Schering-Plough Corporation, The Medicines Company, Heartscape Technologies, Inc.
Fees received for promotional/non-CME activities: sanofi-aventis U.S., Bristol-Myers Squibb, Schering-Plough Corporation, Genentech

Christopher P. Cannon, MD
Fees received for promotional/non-CME activities: Accumetrics, AstraZeneca, Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, GlaxoSmithKline, Merck & Co., Inc.,
Merck/Schering-Plough Partnership
Clinical advisor: equity in Automedics Medical Systems

David M. Larson, MD
Consulting fees/advisory boards: Heartscape Technologies, Inc., The Medicines Company

Rachel A. Karcher, PharmD and the other employees of Med-IQ have no financial relationships to disclose.

Learning Objectives:
Upon completion, participants should be able to:

  • Rapidly assess and accurately diagnose STEMI and NSTEMI patients
  • Initiate reperfusion strategies in STEMI patients according to treatment guidelines
  • Improve door-to-needle time in STEMI patients undergoing fibrinolytic therapy but not transferring to PCI-capable hospitals
  • Use risk stratification measures to guide treatment decisions in NSTEMI patients
  • Implement anticoagulation strategies for STEMI and NSTEMI patients as defined by current guidelines

Series Overview/Statement of Need
Detailed treatment guidelines and hospital protocols exist for the management of ACS patients, but barriers and educational gaps that limit the optimal management of ACS patients are prevalent. Despite effective pharmacologic agents, clinical trials, and the existence of evidence-based strategies that have been shown to improve outcomes, achieving therapeutic goals remains a challenge. This performance improvement initiative in ACS will improve patient care through a multidisciplinary-team framework and will help physicians achieve clinical and practice management benchmarks as defined by the 2007 ACC/AHA STEMI and UA/NSTEMI guideline updates.

Target Audience
This activity is intended for cardiologists and emergency department physicians in non-PCI-capable hospitals.

Accreditation/Designation Statements
Med-IQ is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Med-IQ designates this activity for a maximum of 20.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Evidence-Based Content Statement
Educational activities that assist physicians in carrying out their professional responsibilities more effectively and efficiently are consistent with the ACCME definition of continuing medical education (CME). As an ACCME-accredited provider of CME, it is the policy of Med-IQ to review and ensure that all the content and any recommendations, treatments, and manners of practicing medicine in CME activities are scientifically based, valid, and relevant to the practice of medicine. Med-IQ is responsible for validating the content of the CME activities it provides. Specifically, (1) all recommendations addressing the medical care of patients must be based on evidence that is scientifically sound and recognized as such within the profession; (2) all scientific research referred to, reported, or used in CME in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection and analysis.

Med-IQ is not liable for any decision made or action taken in reliance upon the information provided through this activity.

Acknowledgment of Commercial Support
This series is supported by an educational grant from sanofi-aventis U.S.

sanofi-aventis

Medium and Method of Participation/Instructions to Receive Credit
This CME activity consists of 3 stages. To receive credit, each participant must read the introductory CME material, complete all 3 stages, and complete the corresponding attestation and evaluation.

Copyright
© 2009 Med-IQ. All rights reserved.

Accreditation/Designation Statements: Med-IQ is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Med-IQ designates this activity for a maximum of 20.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

 

sanofi-aventis

Acknowledgement of Commercial Support: This series is
supported by an educational grant from sanofi-aventis U.S.

 

Med-IQ delivers education that brings measurable change in healthcare provider compentency with the goal of improving performance and patient outcomes.

e-mail info@med-iq.com www.med-iq.com